The Meyer Children Hospital is a pediatric hospital located in Florence, Italy. The hospital is an official member of the European Network of Health Promoting Hospitals of the World Health Organization ...

During the past decade, Azienda Ospedaliero-Universitaria Meyer conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 14 clinical trials were completed, i.e. on average, 31.8% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 12 clinical trials were completed. i.e. 54.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliero-Universitaria Meyer" #1 sponsor was "Italian Sarcoma Group" with 6 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Gilead Sciences" with 3 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliero-Universitaria Meyer" #1 collaborator was "Associazione Italiana Ematologia Oncologia Pediatrica" with 2 trials as a collaborator, "Baylor College of Medicine" with 1 trials as a collaborator, "Boston Children's Hospital" with 1 trials as a collaborator, "Children's Hospital of Philadelphia" with 1 trials as a collaborator and "Cystic Fibrosis Foundation" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliero-Universitaria Meyer" are "Cystic Fibrosis" (7 trials), "Juvenile Idiopathic Arthritis" (3 trials), "Sickle Cell Disease" (3 trials), "Epilepsy, Partial Seizures" (2 trials) and "Ewing's Sarcoma" (2 trials). Many other conditions were trialed in "Azienda Ospedaliero-Universitaria Meyer" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliero-Universitaria Meyer" are "Drug" (43 trials), "Other" (11 trials), "Biological" (3 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "IVA" (4 trials), "Doxorubicin" (3 trials), "Etoposide" (3 trials) and "Ifosfamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliero-Universitaria Meyer" are 58 trials for "All" genders.

Currently, there are NaN active trials in "Azienda Ospedaliero-Universitaria Meyer". undefined are not yet recruiting, 16 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Azienda Ospedaliero-Universitaria Meyer, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliero-Universitaria Meyer, 4 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Azienda Ospedaliero-Universitaria Meyer has several departments that took part in Clinical trials: "AOU Anna Meyer - Clinica di Neurologia Pediatrica" - 3 trials, "Neonatal Intensive Care Unit - Azienda Ospedaliero-Universitaria Meyer" - 2 trials